Repertoire Immune Medicines is a clinical-stage biotechnology company focused on discovering and developing programmable immune medicines to prevent or treat cancer, autoimmune diseases, and infectious diseases. The company leverages insights from the adaptive immune system, including its DECODE platform and immune synapse interactions, to design therapies targeting the T cell repertoire. Headquartered in the United States, Repertoire aims to translate immune codes into transformative medicines that can reprogram immune responses in patients.
No recent deals for this company.